Search

Search Results

• Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

  Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

  13-09-2023

  https://doi.org/10.4081/dr.2023.9839

  2288

  PDF: 857

  HTML: 26
• 

  Efficacy of intravenous immunoglobulin monotherapy in patients with cutaneous lupus erythematosus: results of proof-of-concept study

  Christa Ky, Brian Swasdibutra, Shaadi Khademi, Sheetal Desai, Vivian Laquer, Sergei A. Grando

  16-03-2015

  https://doi.org/10.4081/dr.2015.5804

  2444

  PDF: 1042

  HTML: 245
• 

  Combined cetuximab and volumetric modulated arc-radiotherapy in advanced recurrent squamous cell carcinoma of the scalp

  Uwe Wollina, Andreas Schreiber, Knut Merla, Gunter Haroske

  e57

  13-12-2011

  https://doi.org/10.4081/dr.2011.e57

  1757

  PDF: 657

  HTML: 1020
• 

  Post-inflammatory hyperpigmentation after carbon dioxide laser: review of prevention and risk factors

  Alhanouf Bin Dakhil, Asem Shadid, Saad Altalhab

  19-05-2023

  https://doi.org/10.4081/dr.2023.9703

  4010

  PDF: 821

  APPENDIX 1: 107

  HTML: 17

• Regenerative therapies in lichen sclerosus genitalis patients and possible efficacy in preventing squamous cell carcinoma development: a long-term follow-up pilot study

  Marinella Tedesco, Barbara Bellei, Lavinia Alei, Monia Di Prete, Carlo Cota, Tiziano Pallara, Antonio Bonadies, Alessandra Latini, Stefania De Fazio, Emilia Migliano

  27-11-2024

  https://doi.org/10.4081/dr.2024.10079

  514

  PDF: 315

  HTML: 4
• 

  Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

  Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło

  22-05-2023

  https://doi.org/10.4081/dr.2023.9630

  935

  PDF: 490

  HTML: 57

• Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

  Viviana Lora, Dario Graceffa, Monia Di Prete, Carlo Cota

  11-11-2024

  https://doi.org/10.4081/dr.2024.10140

  727

  PDF: 372

  SUPPLEMENTARY MATERIAL: 75

  HTML: 4

• Treatment satisfaction among patients with psoriasis in Saudi Arabia

  Mahdi Aldhafiri, Rahaf Almutairi, Reem Albejais, Asma Almubark, Hussain Alwesaibie, Mohammed Albesher, Manayer Almustihi

  15-04-2024

  https://doi.org/10.4081/dr.2024.9967

  831

  PDF: 440

  HTML: 18

• Cost analysis in the management of moderate-to-severe psoriasis: comparison between conventional and biological systemic therapies

  Edoardo Mortato, Silvia Baratta, Luca Rubino, Anna Paola De Caro, Francesco Loconsole

  19-06-2023

  https://doi.org/10.4081/dr.2023.9755

  744

  PDF: 351

  HTML: 13
• 

  Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

  Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen

  11-10-2017

  https://doi.org/10.4081/dr.2017.7079

  1232

  PDF: 592

  HTML: 138
• 

  Erythrodermic psoriasis improved by tildrakizumab

  Giampaolo Trevisan, Lerica Germi, Luigi Naldi

  23-11-2022

  https://doi.org/10.4081/dr.2022.9448

  1001

  PDF: 543

  HTML: 18

• Effectiveness and safety of tuberculin purified protein derivative for the treatment of anogenital warts in patients with human immunodeficiency virus

  Pati Aji Achdiat, Stephanie Widjaja, Oki Suwarsa, Reiva Farah Dwiyana, Reti Hindritiani, Endang Sutedja, Hendra Gunawan, Hermin Aminah Usman, Fathia Rianty, Retno Hesty Maharani

  30-01-2024

  https://doi.org/10.4081/dr.2024.9754

  754

  PDF: 467

  HTML: 21
• 

  Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

  Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

  19-05-2023

  https://doi.org/10.4081/dr.2023.9692

  918

  PDF: 470

  HTML: 17
• 

  Telangiectasia Macularis Eruptiva Perstans: more than skin deep

  Casey E. Watkins, Winston B. Bokor, Stuart Leicht, George Youngberg, Guha Krishnaswamy

  e12

  29-07-2011

  https://doi.org/10.4081/dr.2011.e12

  11434

  PDF: 2100

  HTML: 2300
• 

  Combination of cyclosporine A and methylprednisolone to treat pediatric Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome

  Shinta Trilaksmi Dewi, Laily Noor Qomariah, Widya Khairunisa Sarkowi, Monika Puspitasari, Miya Khalidah, Marcella Anggatama, Dwinanda Almira Rizkiani, Kristiana Etnawati, Sri Awalia Febriana

  19-06-2023

  https://doi.org/10.4081/dr.2023.9656

  1132

  PDF: 559

  HTML: 171

• A microRNA focus on acne

  Sarah Gordon, Alison M. Layton, Sandra Fawcett, Kehinde Ross

  02-02-2024

  https://doi.org/10.4081/dr.2024.9902

  891

  PDF: 611

  HTML: 51
• 

  Garlic in dermatology

  Nader Pazyar, Amir Feily

  e4

  28-04-2011

  https://doi.org/10.4081/dr.2011.e4

  8980

  PDF: 1655

  HTML: 677

• COVID-19 infection in chronic spontaneous urticaria treated with omalizumab: two case reports

  Angelo Massimiliano D'Erme, Cristian Fidanzi, Marco Romanelli, Valentina Dini, Giovanni Bagnoni, Agata Janowska

  24-08-2023

  https://doi.org/10.4081/dr.2023.9763

  709

  PDF: 353

  HTML: 24

• Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

  Gioele Ghezzi, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

  12-11-2024

  https://doi.org/10.4081/dr.2024.10080

  933

  PDF: 463

  HTML: 10
• 

  Atopic dermatitis: a brief review of recent advances in its management

  Sultan Daghafak Alenazi

  23-05-2023

  https://doi.org/10.4081/dr.2023.9678

  2115

  PDF: 1271

  HTML: 75
• 

  Possible relationship between poor skin disorders prognosis and serum zinc level: a narrative review

  Mohammed Al Abadie, Zinah Sharara, Miriam Al Abadie, Patrick A. Ball, Hana Morrissey

  06-07-2022

  https://doi.org/10.4081/dr.2022.9512

  1926

  PDF: 841

  HTML: 224

• A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks

  Luciano Ibba, Luigi Gargiulo, Giulia Pavia, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

  06-06-2023

  https://doi.org/10.4081/dr.2023.9722

  673

  PDF: 389

  HTML: 14

• CD4/CD8 double-negative mycosis fungoides: a review

  Khalid Nabil Nagshabandi, Abdulrahman Shadid, Asem Shadid, Nouf K. Almuhanna

  12-04-2024

  https://doi.org/10.4081/dr.2024.9908

  2975

  PDF: 536

  SUPPLEMENTARY: 69

  HTML: 12

• Mendelian randomization analysis of the causal relationship between immune cells and keloid

  Jingwen Zou, Pengkhun Nov, Kunpeng Du

  23-10-2024

  https://doi.org/10.4081/dr.2024.10106

  476

  PDF: 268

  SUPPLEMENTARY MATERIAL: 77

  HTML: 2
• 

  Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

  Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza

  21-11-2022

  https://doi.org/10.4081/dr.2022.9447

  1207

  PDF: 352

  HTML: 39